Background: The aim of this study is to review our experience with using more than 2,000 RAs over the last seven years, and to assess the medium-term outcome in terms of morbidity and mortality. Methods: Between June 1994 and June 2001, a total of 2,024 RAs have been used in 1,613 patients. The mean duration of follow-up was 40.1 months and ranged from one to 88 months. We assessed the results of postoperative mortality and morbidity, RA graft patency, coro-nary event free rate, and actuarial survival rate. Specifically, the independent predictors of early and late mortalities were examined. Results: Perioperative myocardial infarction was indicated in 0.8%, stroke in 1.6%, respec-tively. Overall hospital mortality was 35 patients (2.4%)...
I would like to congratulate the authors on providing a useful insight on the controversial issue of...
Background: Redo coronary artery bypass grafting surgery (CABG) is associated with a higher risk of ...
Background: We compared the outcomes in patients with a low ejection fraction (EF) and multivessel c...
BACKGROUND: There is a lack of evidence for the choice of the second conduit in coronary surgery. Th...
Purpose: The radial artery is used to supplement internal mammary arteries and vein grafts in corona...
Study objectives: The aim of this study was to evaluate the immediate and midterm results of coronar...
Objectives: The use of the radial artery as a second arterial graft during coronary surgery has grow...
Objective: Long-term studies have shown that internal thoracic artery (ITA) has a higher patency rat...
OBJECTIVE: This study aimed at evaluating the clinical and angiographic results of the radial artery...
Introduction: Coronary artery disease (CAD) is the most common heart disease in the United States, o...
Background: Radial artery (RA) was the second arterial graft introduced in clinical practice for myo...
It is generally accepted that radial artery (RA) grafts have better mid-term patency rate compared t...
OBJECTIVE: Little evidence shows whether the radial artery (RA) as third arterial graft provides sup...
It is generally accepted that radial artery (RA) grafts have better mid-term patency rate compared t...
OBJECTIVE: Little evidence shows whether the radial artery (RA) as third arterial graft provides sup...
I would like to congratulate the authors on providing a useful insight on the controversial issue of...
Background: Redo coronary artery bypass grafting surgery (CABG) is associated with a higher risk of ...
Background: We compared the outcomes in patients with a low ejection fraction (EF) and multivessel c...
BACKGROUND: There is a lack of evidence for the choice of the second conduit in coronary surgery. Th...
Purpose: The radial artery is used to supplement internal mammary arteries and vein grafts in corona...
Study objectives: The aim of this study was to evaluate the immediate and midterm results of coronar...
Objectives: The use of the radial artery as a second arterial graft during coronary surgery has grow...
Objective: Long-term studies have shown that internal thoracic artery (ITA) has a higher patency rat...
OBJECTIVE: This study aimed at evaluating the clinical and angiographic results of the radial artery...
Introduction: Coronary artery disease (CAD) is the most common heart disease in the United States, o...
Background: Radial artery (RA) was the second arterial graft introduced in clinical practice for myo...
It is generally accepted that radial artery (RA) grafts have better mid-term patency rate compared t...
OBJECTIVE: Little evidence shows whether the radial artery (RA) as third arterial graft provides sup...
It is generally accepted that radial artery (RA) grafts have better mid-term patency rate compared t...
OBJECTIVE: Little evidence shows whether the radial artery (RA) as third arterial graft provides sup...
I would like to congratulate the authors on providing a useful insight on the controversial issue of...
Background: Redo coronary artery bypass grafting surgery (CABG) is associated with a higher risk of ...
Background: We compared the outcomes in patients with a low ejection fraction (EF) and multivessel c...